DNDI-6174, a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1 complex

od Braillard, Stéphanie, Keenan, Martine, Breese, Karen J., Heppell, Jacob, Abbott, Michael, Islam, Rafiqul, Shackleford, David M., Katneni, Kasiram, Crighton, Elly, Chen, Gong, Patil, Rahul, Lee, Given, White, Karen L., Carvalho, Sandra, Wall, Richard J., Chemi, Giulia, Zuccotto, Fabio, González, Silvia, Marco, Maria, Deakyne, Julianna, Standing, David, Brunori, Gino, Lyon, Jonathan J., Castañeda Casado, Pablo, Camino, Isabel, Martinez, Maria S. Martinez, Zulfiqar, Bilal, Avery, Vicky M., Feijens, Pim-Bart, Van Pelt, Natascha, Matheeussen, An, Hendrickx, Sarah, Maes, Louis, Caljon, Guy, Yardley, Vanessa, Wyllie, Susan, Charman, Susan A., Chatelain, Eric
izdano v Sci Transl Med (2023)